On Tuesday, SanDisk Corporation (NASDAQ:SNDK)’s shares declined -0.27% to $59.30.
SanDisk Corporation ( SNDK), a global leader in flash storage solutions, recently declared it has reached agreement with SK Hynix, Inc. to modify and extend their intellectual property licensing relationship and enter into a multi-year commercial relationship under which SK Hynix will supply its leading-edge DRAM products to SanDisk. These agreements comprise a settlement of the trade secret misappropriation suit filed by SanDisk in 2014.
Under these agreements, which will expire on March 31, 2023, SanDisk will release SK Hynix of its liability pertaining to the trade secret litigation and license certain intellectual property rights to SK Hynix in exchange for license and royalty payments to be made over the duration of the agreement. In addition, SK Hynix has agreed to supply SanDisk with certain volumes of its DRAM products for MCP and SSD applications. The specific terms and conditions of the agreements, counting with respect to economic consideration, are confidential.
SanDisk Corporation designs, develops, manufactures, and markets data storage solutions in the United States and internationally. The company offers removable cards, which are used in various applications and consumer devices, counting digital cameras, camcorders, smartphones, tablets, and eReaders under the SanDisk Ultra, SanDisk Extreme, and SanDisk Extreme PRO brands; and embedded products that are used in mobile phones, tablets, notebooks, and other portable and wearable devices, in addition to in automotive and connected home applications under the brand name iNAND.
Cameco Corporation (USA) (NYSE:CCJ)’s shares gained 0.58% to $13.80.
Cameco (CCO.TO)(CCJ) stated its merged financial and operating results for the second quarter ended June 30, 2015 in accordance with International Financial Reporting Standards (IFRS).
SECOND QUARTER
Net earnings attributed to equity holders this quarter were $88 million ($0.22 per share diluted) contrast to net earnings of $127 million ($0.32 per share diluted) in the second quarter of 2014. In addition to the items noted below, our net earnings were affected by mark-to-market gains on foreign exchange derivatives.
On an adjusted basis, our earnings this quarter were $46 million ($0.12 per share diluted) contrast to $79 million ($0.20 per share diluted) (non-IFRS measure, see section) in the second quarter of 2014. The change was mainly due to:
- higher administrative costs
- a favourable settlement of $28 million with respect to a dispute regarding a long-term supply contract with a utility customer recorded in the second quarter of 2014
partially offset by:
- higher gross profit from uranium and fuel services segments
- settlement costs of $12 million with respect to the early redemption our Series C debentures recorded during the second quarter of 2014
Cameco Corporation produces and sells uranium worldwide. The company operates through Uranium, Fuel Services, and NUKEM segments. The Uranium segment is involved in the exploration for, mining, and milling of uranium concentrates. Its operating uranium properties comprise the McArthur River and Key Lake, Cigar Lake, and Rabbit Lake properties located in Saskatchewan, Canada; the Smith Ranch-Highland property located in Wyoming; the Crow Butte property located in Nebraska; and the Inkai property located in Kazakhstan.
At the end of Tuesday’s trade, Tenet Healthcare Corp (NYSE:THC)‘s shares surged 1.39% to $57.50.
Tenet Healthcare Corporation (THC) stated Adjusted EBITDA of $568 million for the second quarter of 2015, an enhance of $108 million, or 23.5 percent, contrast to $460 million in the second quarter of 2014. The results for the second quarter of 2015 comprised of $16 million of Adjusted EBITDA generated by United Surgical Partners International (USPI) and Aspen Healthcare, which were attained by Tenet on June 16, 2015.
Tenet generated same-hospital growth in admissions and adjusted admissions of 1.7 percent and 2.3 percent, respectively, contrast to the second quarter of 2014. Paying admissions raised 2.1 percent, reflecting growth in the number of newly insured patients. Surgeries performed in our hospital segment raised 1.5 percent and emergency department visits raised 2.4 percent. On a pro forma same-facility system-wide basis, counting the results of USPI and Aspen in both the second quarters of 2015 and 2014, surgical and imaging cases in our Ambulatory Care segment grew by 6.8 percent.
The company continues to benefit from declines in uninsured and charity volumes. In the six states in which we operate that expanded their Medicaid programs, same-hospital uninsured plus charity admissions declined by 639 admissions, or 31.5 percent, and Medicaid admissions raised by 767 admissions, or 2.6 percent. Uninsured plus charity outpatient visits reduced by 8,729 visits, or 15.8 percent, and Medicaid outpatient visits grew by 32,714 visits, or 9.2 percent. The six states are comprised of five states that expanded Medicaid in 2014 (Arizona, California, Illinois, Massachusetts and Michigan) and one state that expanded Medicaid in 2015 (Pennsylvania).
Tenet Healthcare Corporation, a healthcare services company, primarily operates acute care hospitals and related healthcare facilities in the United States. It operates through two segments, Hospital Operations and Other, and Conifer. The company’s general hospitals offer acute care services, operating and recovery rooms, radiology services, respiratory therapy services, clinical laboratories, and pharmacies.
Orbitz Worldwide, Inc. (NYSE:OWW), ended its Tuesday’s trading session with 0.36% gain, and closed at $11.24.
Visa Inc. (V) declared it is working with Orbitz for Business, the corporate travel brand of Orbitz Worldwide (OWW), to provide corporate clients with a turn-key, end-to-end travel and expense solution designed to make booking, reconciliation and reporting more efficient. The solution, Visa Travel Manager, is specifically designed to give mid-market companies control of, and visibility into, employee travel spending. It is planned to be accessible to Visa issuers and their clients starting October 2015.
Visa Travel Manager combines an Orbitz-powered booking and payment portal on the front end with Visa IntelliLink reporting and expense administration on the back end. This integration gives companies a greater ability to capture total travel spend and have raised visibility across their organization, promote compliance, and provide data intelligence to drive cost savings.
Orbitz Worldwide, Inc. operates as an online travel company worldwide. It uses technology that enables leisure and business travelers to research, plan, and book a range of travel products and services, counting hotels, flights, vacation packages, car rentals, rail tickets, cruises, travel insurance, destination, services and event tickets.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
